ALLO vs REGN: Which Stock is Better?

Side-by-side comparison of Allogene Therapeutics Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

ALLO

Allogene Therapeutics Inc

$2.15

REGN

Regeneron Pharmaceuticals Inc

$737.45

Key Metrics Comparison

MetricALLOREGNWinner
Market Cap$510.14M$78.67BREGN
P/E RatioN/A17.95REGN
EPS (TTM)$N/A$41.45REGN
Revenue Growth-1.0%0.0%REGN
Gross Margin0.0%44.6%REGN

Analyze ALLO

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ALLO or REGN a better investment?

Comparing ALLO and REGN: Allogene Therapeutics Inc has a market cap of $510.14M while Regeneron Pharmaceuticals Inc has $78.67B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ALLO and REGN?

ALLO (Allogene Therapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ALLO or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ALLO or REGN?

REGN has higher revenue growth at 0.0% vs -1.0% for ALLO.

Which company is more profitable: ALLO or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for ALLO.

Which is the larger company: ALLO or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.67B compared to $510.14M for ALLO.

Should I buy ALLO or REGN in 2026?

Both ALLO and REGN have investment merit. ALLO trades at $2.15 while REGN trades at $737.45. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ALLO and REGN stock?

Key differences: Market Cap ($510.14M vs $78.67B), P/E Ratio (N/A vs 18.0x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).

Popular Stock Comparisons